Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 04 2022
Historique:
received: 07 02 2022
accepted: 04 04 2022
entrez: 26 4 2022
pubmed: 27 4 2022
medline: 28 4 2022
Statut: epublish

Résumé

The global spread of SARS-CoV-2 led to major economic and health challenges worldwide. Revealing host genes essential for infection by multiple variants of SARS-CoV-2 can provide insights into the virus pathogenesis, and facilitate the development of novel therapeutics. Here, employing a genome-scale CRISPR screen, we provide a comprehensive data-set of cellular factors that are exploited by wild type SARS-CoV-2 as well as two additional recently emerged variants of concerns (VOCs), Alpha and Beta. We identified several host factors critical for SARS-CoV-2 infection, including various components belonging to the Clathrin-dependent transport pathway, ubiquitination, Heparan sulfate biogenesis and host phosphatidylglycerol biosynthesis. Comparative analysis of the different VOCs revealed the host factors KREMEN2 and SETDB1 as potential unique candidates required only to the Alpha variant. Furthermore, the analysis identified GATA6, a zinc finger transcription factor, as an essential proviral gene for all variants inspected. We show that GATA6 directly regulates ACE2 transcription and accordingly, is critical for SARS-CoV-2 cell entry. Analysis of clinical samples collected from SARS-CoV-2 infected individuals shows elevated levels of GATA6, suggesting a role in COVID-19 pathogenesis. Finally, pharmacological inhibition of GATA6 resulted in down-modulation of ACE2 and inhibition of viral infectivity. Overall, we show GATA6 may represent a target for the development of anti-SARS-CoV-2 therapeutic strategies and reaffirm the value of the CRISPR loss-of-function screens in providing a list of potential new targets for therapeutic interventions.

Identifiants

pubmed: 35469023
doi: 10.1038/s41467-022-29896-z
pii: 10.1038/s41467-022-29896-z
pmc: PMC9039069
doi:

Substances chimiques

GATA6 Transcription Factor 0
GATA6 protein, human 0
Peptidyl-Dipeptidase A EC 3.4.15.1
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2237

Informations de copyright

© 2022. The Author(s).

Références

Elife. 2020 Oct 28;9:
pubmed: 33112236
Nature. 2021 Jun;594(7862):240-245
pubmed: 33979833
Commun Biol. 2021 Mar 5;4(1):290
pubmed: 33674719
Cell Res. 2008 Feb;18(2):290-301
pubmed: 18227861
Sci Rep. 2020 Nov 10;10(1):19395
pubmed: 33173052
Gene. 2006 Aug 1;377:46-55
pubmed: 16781089
Annu Rev Microbiol. 2019 Sep 8;73:529-557
pubmed: 31226023
Viruses. 2019 Jul 01;11(7):
pubmed: 31266258
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Nat Rev Immunol. 2021 Apr;21(4):198-199
pubmed: 33712744
Nat Commun. 2018 Apr 12;9(1):1424
pubmed: 29651155
Genes (Basel). 2019 Oct 12;10(10):
pubmed: 31614829
Int J Mol Sci. 2021 Jul 13;22(14):
pubmed: 34299101
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Biochim Biophys Acta. 2013 Nov;1829(11):1225-35
pubmed: 24100303
Biomed Environ Sci. 2011 Feb;24(1):81-7
pubmed: 21440844
Cell. 2021 Jan 7;184(1):106-119.e14
pubmed: 33333024
Cell Host Microbe. 2021 Feb 10;29(2):267-280.e5
pubmed: 33357464
Nat Rev Drug Discov. 2021 Sep;20(9):669-688
pubmed: 34006959
Genes Dev. 1998 Jul 15;12(14):2153-63
pubmed: 9679060
Genes Dev. 2002 Apr 15;16(8):919-32
pubmed: 11959841
Nat Biotechnol. 2016 Feb;34(2):184-191
pubmed: 26780180
Nat Genet. 2022 Aug;54(8):1090-1102
pubmed: 35879413
Gene. 2013 Dec 1;531(2):126-32
pubmed: 23069847
J Adv Res. 2020 Mar 16;24:91-98
pubmed: 32257431
Nat Commun. 2021 Feb 11;12(1):961
pubmed: 33574281
J Biol Chem. 2021 Jan-Jun;296:100306
pubmed: 33476648
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
N Engl J Med. 2021 Apr 15;384(15):1412-1423
pubmed: 33626250
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
Elife. 2019 Jan 11;8:
pubmed: 30632963
J Biol Chem. 2000 Jan 14;275(2):1043-9
pubmed: 10625644
Cell. 2020 Nov 12;183(4):1043-1057.e15
pubmed: 32970989
Biochem Biophys Res Commun. 2008 May 30;370(2):366-70
pubmed: 18381204
J Virol. 2013 Jun;87(11):6150-60
pubmed: 23536651
Viruses. 2021 Feb 26;13(3):
pubmed: 33652634
PLoS One. 2016 Apr 01;11(4):e0152385
pubmed: 27035130
Front Immunol. 2018 Sep 28;9:2229
pubmed: 30323812
J Proteome Res. 2021 May 7;20(5):2224-2239
pubmed: 33666082
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81
pubmed: 16081529
Cell. 2021 Jan 7;184(1):76-91.e13
pubmed: 33147444
Cell Host Microbe. 2018 May 9;23(5):636-643.e5
pubmed: 29681460
Cell. 2021 Jan 7;184(1):120-132.e14
pubmed: 33382968
Genome Biol. 2014;15(12):554
pubmed: 25476604
N Engl J Med. 2021 May 13;384(19):1866-1868
pubmed: 33761203
J Transl Med. 2021 Jan 7;19(1):32
pubmed: 33413422
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Cell. 2021 Jan 7;184(1):92-105.e16
pubmed: 33147445
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
Nature. 2021 Jun;594(7862):246-252
pubmed: 33845483
J Biol Chem. 2020 Sep 11;295(37):12910-12934
pubmed: 32661197
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nature. 2021 Jan;589(7840):125-130
pubmed: 32906143
Nat Rev Cancer. 2019 Nov;19(11):611-624
pubmed: 31511663
Nature. 2002 Jun 6;417(6889):664-7
pubmed: 12050670
Med Hypotheses. 2020 Nov;144:110277
pubmed: 33254581
Lancet Microbe. 2021 Jul;2(7):e285
pubmed: 33870240
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
J Virol. 2013 Dec;87(23):12552-61
pubmed: 24027332
Cell. 2015 Dec 3;163(6):1515-26
pubmed: 26627737
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
J Biol Chem. 2019 Mar 22;294(12):4282-4289
pubmed: 30733339
Nat Genet. 2021 Apr;53(4):435-444
pubmed: 33686287
Structure. 2016 Sep 6;24(9):1599-605
pubmed: 27524201
Cell Mol Immunol. 2021 Mar;18(3):746-748
pubmed: 33473190
Nat Genet. 2022 Aug;54(8):1078-1089
pubmed: 35879412
Sci Rep. 2019 Nov 22;9(1):17335
pubmed: 31758034
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
N Engl J Med. 2021 May 20;384(20):1885-1898
pubmed: 33725432
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Nat Commun. 2020 Dec 16;11(1):6402
pubmed: 33328475
Elife. 2016 Aug 15;5:
pubmed: 27525483
Science. 2020 Dec 4;370(6521):
pubmed: 33060197

Auteurs

Ma'ayan Israeli (M)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Yaara Finkel (Y)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.

Yfat Yahalom-Ronen (Y)

Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.

Nir Paran (N)

Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.

Theodor Chitlaru (T)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Ofir Israeli (O)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Inbar Cohen-Gihon (I)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Moshe Aftalion (M)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Reut Falach (R)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Shahar Rotem (S)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Uri Elia (U)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Ital Nemet (I)

Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Limor Kliker (L)

Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Michal Mandelboim (M)

Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.

Adi Beth-Din (A)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Tomer Israely (T)

Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.

Ofer Cohen (O)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel.

Noam Stern-Ginossar (N)

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.

Adi Bercovich-Kinori (A)

Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness Ziona, Israel. adiki@iibr.gov.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH